Takafumi Hiro
Overview
Explore the profile of Takafumi Hiro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
111
Citations
1619
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yoshiki Y, Ozaki Y, Abe M, Ismail T, Takahashi H, Akao M, et al.
J Am Heart Assoc
. 2025 Jan;
14(2):e034627.
PMID: 39818975
Background: The effect of worsening renal function and baseline chronic kidney disease (CKD) on outcomes in patients with chronic coronary syndrome in the setting of optimal medical therapy remains unknown....
2.
Hibi K, Gohbara M, Uemura K, Iwahashi N, Okada K, Iwata H, et al.
J Clin Lipidol
. 2024 Sep;
18(5):e844-e854.
PMID: 39278769
Background And Aims: Previous studies have not found a consistent association between circulating proprotein convertase subtilisin/kexin type 9 (PCSK9) levels and the risk of cardiovascular events partly due to measurement...
3.
Morikawa T, Hiro T, Mineki T, Kojima K, Kogo T, Iida K, et al.
Heart Vessels
. 2024 Aug;
40(1):16-25.
PMID: 39172189
The main cause of acute coronary syndrome (ACS) is plaque rupture and thrombus formation. However, it has not been fairly successful to identify vulnerable plaque to rupture using conventional parameters...
4.
Mitsutake Y, Ishii J, Fukumoto Y, Ito S, Kashiwabara K, Uemura K, et al.
Int J Cardiol
. 2023 Jun;
387:131138.
PMID: 37355235
Background: This study aimed to examine whether high-sensitivity cardiac troponin-I (hsTnI) and N-terminal pro-brain natriuretic peptide (NT-proBNP) could predict future major adverse cardiovascular events (MACE) in stable coronary artery disease...
5.
Morinaga J, Kashiwabara K, Torigoe D, Okadome Y, Aizawa K, Uemura K, et al.
Arterioscler Thromb Vasc Biol
. 2023 Jun;
43(8):1549-1559.
PMID: 37259862
Background: The ability to predict secondary cardiovascular events could improve health of patients undergoing statin treatment. Circulating ANGPTL8 (angiopoietin-like protein 8) levels, which positively correlate with proatherosclerotic lipid profiles, activate...
6.
Okumura Y, Nagashima K, Watanabe R, Yokoyama K, Kato T, Fukaya H, et al.
BMJ Open
. 2023 Feb;
13(2):e068894.
PMID: 36792334
Introduction: Data are lacking on the extent to which patients with non-valvular atrial fibrillation (AF) who are aged ≥80 years benefit from ablation treatment. The question pertains especially to patients'...
7.
Ishii J, Kashiwabara K, Ozaki Y, Takahashi H, Kitagawa F, Nishimura H, et al.
J Atheroscler Thromb
. 2021 Dec;
29(10):1458-1474.
PMID: 34880156
Aim: We investigated the relationship between small dense low-density cholesterol (sdLDL-C) and risk of major adverse cardiovascular events (MACE) in patients treated with high- or low-dose statin therapy. Methods: This...
8.
Oshima T, Kojima K, Hiro T, Murata N, Fukamachi D, Hirayama A, et al.
Int J Cardiovasc Imaging
. 2021 Aug;
37(12):3381-3383.
PMID: 34374901
No abstract available.
9.
Abe M, Ozaki Y, Takahashi H, Ishii M, Masunaga N, Ismail T, et al.
Am Heart J
. 2021 Jun;
240:89-100.
PMID: 34174217
Background: It has not yet been established whether higher-dose statins have beneficial effects on cardiovascular events in patients with stable coronary artery disease (CAD) and renal dysfunction. Methods: The REAL-CAD...
10.
Iida K, Hiro T, Fukamachi D, Sudo M, Nishida T, Akutsu N, et al.
J Atheroscler Thromb
. 2021 Mar;
29(4):464-473.
PMID: 33658453
Aim: Coronary plaque rupture is the main cause of acute coronary syndrome (ACS), but the role of blood flow features around plaque rupture for ACS is still unknown. The present...